Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screeningPasi A Jänne, Ana M Borras, Yanan Kuang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2015
Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer PatientsCloud P Paweletz, Adrian G Sacher, Chris K Raymond, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2019
Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal TumorsCésar Serrano, Alessandro Leal, Yanan Kuang, et al.Cancer Research|August 19, 2015
Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase InhibitionMargaret Soucheray, Marzia Capelletti, Inés Pulido, et al.Nature Genetics|August 25, 2015
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancerMichalina Janiszewska, Lin Liu, Vanessa Almendro, et al.Cancer Discovery|October 4, 2016
Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung CancerMagda Bahcall, Taebo Sim, Cloud P Paweletz, et al.Nature Medicine|May 5, 2015
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790MKenneth S Thress, Cloud P Paweletz, Enriqueta Felip, et al.NPJ Breast Cancer|August 8, 2018
Unraveling the clinicopathological features driving the emergence of <i>ESR1</i> mutations in metastatic breast cancerYanan Kuang, Bilal Siddiqui, Jiani Hu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2023
Early Changes in Circulating Cell-Free KRAS G12C Predict Response to Adagrasib in KRAS Mutant Non-Small Cell Lung Cancer PatientsCloud P Paweletz, Grace A Heavey, Yanan Kuang, et al.Molecular Cancer Therapeutics|November 18, 2021
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent ResistanceMagda Bahcall, Cloud P Paweletz, Yanan Kuang, et al.Pageof 3